Product Images Cisatracurium Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Cisatracurium Besylate NDC 55150-286 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1. Maximum Percent Change from Preinjection in HR and MAP During First 5 Minutes after Initial 4 × ED95 to 8 × ED95 Cisatracurium Doses in Healthy Adults Who Received Opioid/Nitrous Oxide/Oxygen Anesthesia (n = 44) - cisatracurium fig1
The text is not available as it lacks context and does not form a coherent description.*
Figure 2. Percent Change from Preinjection in HR and MAP 10 Minutes After an Initial 4 × ED95 to 8 × ED95 Cisatracurium Dose in Patients Undergoing CABG Surgery Receiving Oxygen/Fentanyl/Midazolam/Anesthesia (n = 54) - cisatracurium fig2
The given text is describing a table or a graph with three rows and two columns displaying an alternating pattern of two percentages, +60% and -60% against the heading "HR". It is not clear what the chart represents or what the percentages denote.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg per 10 mL (2 mg per mL) - Container Label - cisatracurium fig3
This is a warning label for a drug called Cisatracurium Besylate Injection, which contains a paralyzing agent that can cause respiratory arrest. Facilities must be available for artificial respiration. The drug should be stored at 2°-8°C and protected from light. It comes in a multiple-dose vial and contains benzyl alcohol as a preservative. The label also provides information on the manufacturer and distributor of the drug.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg per 10 mL (2 mg per mL) - Container-Carton (10 Vials) - cisatracurium fig4
This is a package insert for an intravenous injection medication called Cisatracurium besylate, containing 20mg per 10mL (2mg per mL) of the active ingredient. The medication is a paralyzing agent and also contains benzyl alcohol as a preservative. The injection is intended for use as an anesthetic during certain medical procedures. It must be stored at a temperature between 2°C and 8°C and must not be frozen. The dosage should follow the instructions provided in the package insert. The medication is distributed by AuroMedics Pharma LLC and is made in India.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2 mg/mL - Peel-off Sticker Label - cisatracurium fig5
This is a label of Cisatracurium Besylate Injection, USP which shows the strength of the injection in mg/mL. It also gives instructions to peel off and apply to syringe b. Additionally, it provides information on the date and time of manufacture or processing, which is Dt Tm: By: P1416958.*
Chemical Structure - cisatracurium str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.